Table 2.
BD (n = 75) | |
---|---|
BD-I | 26 (35%) |
BD-II | 23 (31%) |
BD-NOS | 26 (35%) |
Age of onset | 14.81 ± 2.66 |
Lifetime clinical characteristics | |
Lifetime psychosis | 8 (11%) |
Lifetime suicide attempts | 12 (16%) |
Lifetime self-injurious behaviour | 38 (51%) |
Lifetime suicidal ideation | 47 (63%) |
Legal history (police contact/arrest) | 19 (25%) |
Lifetime physical abuse | 2 (3%) |
Lifetime sexual abuse | 3 (4%) |
Lifetime any abuse (physical and/or sexual) | 4 (5%) |
Lifetime psychiatric hospitalization | 37 (49%) |
Lifetime comorbid diagnoses | |
ADHD | 37 (49%) |
Anxiety disorder | 61 (81%) |
Number of anxiety disorders | 1.63 ± 1.21 |
Conduct disorder | 3 (4%) |
Oppositional defiant disorder | 19 (25%) |
Substance use disorder | 17 (23%) |
Nicotine use | 11 (15%) |
Lifetime medications | |
Second generation antipsychotics | 55 (73%) |
Lithium | 19 (25%) |
Non-SSRI antidepressants | 14 (19%) |
SSRI antidepressant | 25 (33%) |
Stimulants | 16 (21%) |
Current medications | |
Second generation antipsychotics | 44 (59%) |
Lithium | 14 (19%) |
Non-SSRI antidepressants | 4 (5%) |
SSRI antidepressants | 7 (9%) |
Stimulants | 5 (7%) |
Family psychiatric history | |
Mania/hypomania | 36 (48%) |
Depression | 55 (73%) |
Anxiety | 46 (61%) |
ADHD | 25 (33%) |
Abbreviations: ADHD, attention deficit-hyperactivity disorder; BD, bipolar disorder; HC, healthy control; NOS, not otherwise specified; SSRI, selective serotonin reuptake inhibitor.
Results are reported in mean ± SD or percentage (%) yes unless otherwise specified.